Programa de informaçöes sobre açäo interferente de medicamentos nas análises clínico-laboratoriais. Parte I: Açäo interferente de medicamentos antiinflamatórios (ácido acetilsalicílico, paracetamol, dipirona, piroxicam)

Pedrazzi, Antenor Henrique Pinto; Franco, Joäo José; Zanardo Filho, Antônio.
Rev. bras. anal. clin ; 26(2): 53-61, 1994.
Artículo en Portugués | LILACS | ID: lil-269375

Documentos relacionados

  1. Additive or synergistic analgesic effect of metamizole on standard pain treatment at home after arthroscopic shoulder surgery: A randomised controlled superiority trial.
  2. [Adequacy of the safety of metamizole and agranulocytosis].
  3. [Agranulocytosis after use of metamizole - an underestimated risk?]
  4. [Recommendations for the perioperative use of dipyrone : Expert recommendation of the working group on acute pain of the German Pain Society, the scientific working group on pain medicine of the German Society for Anesthesiology and Intensive Care Medicine and the surgical working group on acute pain of the German Society for Surgery with participation of representatives of the Drug Commission of the German Medical Association].
  5. [Metamizol: current status in Dutch practice].
  6. [ACUTE RENAL FAILURE INDUCED BY METAMIZOLE].
  7. [Recommendations for the perioperative use of dipyrone : Expert recommendation of the working group on acute pain of the German Pain Society, the scientific working group on pain medicine of the German Society for Anesthesiology and Intensive Care Medicine and the surgical working group on acute pain of the German Society for Surgery with participation of representatives of the Drug Commission of the German Medical Association].
  8. Safety of metamizole: a systematic review of the literature.
  9. NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.
  10. Further evidence for the hepatotoxic potential of metamizole.